Manas Resources EBITDA margin
Was ist das EBITDA margin von Manas Resources?
EBITDA margin von Manas Resources Limited ist -1,983.95%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Materials Sektor auf ASX im Vergleich zu Manas Resources
Was macht Manas Resources?
Manas Resources Limited engages in the acquisition, exploration, evaluation, and development of gold properties in Australia. Its principal properties include the Mbengué project that covers an area of approximately 400 square kilometers; Eburnea project; and Gonsan project comprising 3 exploration permit applications covering a combined area of approximately 1,000 square kilometers located in Côte D'Ivoire. Manas Resources Limited was incorporated in 2007 and is based in Mount Hawthorn, Australia.
Unternehmen mit ebitda margin ähnlich Manas Resources
- AFC plc hat EBITDA margin von -2,006.21%
- AFC plc hat EBITDA margin von -2,006.21%
- Shree Minerals hat EBITDA margin von -1,996.58%
- Mirati Therapeutics Inc hat EBITDA margin von -1,991.78%
- Nanoveu hat EBITDA margin von -1,986.23%
- Helius Medical Technologies Inc hat EBITDA margin von -1,984.85%
- Manas Resources hat EBITDA margin von -1,983.95%
- Fourth Wave hat EBITDA margin von -1,972.64%
- Skychain Technologies hat EBITDA margin von -1,970.98%
- DBV Technologies hat EBITDA margin von -1,960.96%
- Sultan Resources hat EBITDA margin von -1,947.34%
- Kronos Bio hat EBITDA margin von -1,945.08%
- Havn Life Sciences Inc hat EBITDA margin von -1,929.90%